Very impressed that #Gilead will donate it's stockpile of #Remdesivir. It's wonderful how some companies have really stepped up. Alas, it only seems to possibly short the length of time people are sick by a few days, but has no affect on mortality rates. So it will ease people's duration of suffering but nothing more.
I tend to look down on companies that depend on buying up others to fuel their research and growth, especially at high valuations when their own stock has a low valuation. I'd be somewhat neutral on this buyout. The real winner is $KITE and their competitors, not #Gilead.
Corona
Very impressed that #Gilead will donate it's stockpile of #Remdesivir. It's wonderful how some companies have really stepped up. Alas, it only seems to possibly short the length of time people are sick by a few days, but has no affect on mortality rates. So it will ease people's duration of suffering but nothing more.
Gilead Sciences Takes First Step Towards Higher Valuation Multiple
I tend to look down on companies that depend on buying up others to fuel their research and growth, especially at high valuations when their own stock has a low valuation. I'd be somewhat neutral on this buyout. The real winner is $KITE and their competitors, not #Gilead.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.
Gilead Sciences: Cheap Growth Or Value Trap?
Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD